Skip to main content
. 2021 Apr 16;100(15):e25399. doi: 10.1097/MD.0000000000025399

Table 1.

Baseline characteristics of elderly patients living with HIV/AIDS in Nigeria (N = 15,018).

Variable Normal weight (18.5 ≤ BMI < 25; N = 12967) Obese (BMI ≥30; N = 2015) P-value Total participants (N = 15,018)
Socio-demographics
 Age (yr), mean (SD) 57.1 (6.6) 56.5 (5.5) <.001 56.9 (6.4)
 Age categories (yr) (%) .09
  50 – <60 9347 (72.1%) 1510 (73.6%) 10,857 (72.3%)
  60 – <70 2881 (22.2%) 473 (23.1%) 3354 (22.3%)
  70 and above 739 (5.7%) 68 (3.3%) 807 (5.4%)
 Gender (%)
  Female 6562 (50.6%) 1402 (68.4%) <.001 7964 (53.0%)
  Male 6405 (49.4%) 649 (31.6%) 7054 (47.0%)
 Marital status (%)
  Single 583 (5.1%) 79 (4.3%) .009 662 (5.0%)
  Married 8099 (70.4%) 1274 (69.5%) 9.373 (70.3%)
  Widowed 2101 (18.3%) 354 (19.3%) 2455 (18.4%)
  Divorced 304 (2.6%) 58 (3.2%) 362 (2.7%)
  Separated 422 (3.7%) 67 (3.7%) 489 (3.6%)
 Occupation (%)
  Unemployed 5266 (49.9%) 908 (56.2%) <.001 6174 (50.7%)
  Employed 5287 (50.1%) 707 (43.8%) 5994 (49.3%)
 Education (%)
  None 1832 (17.9%) 212 (13.1%) <.001 2044 (17.2%)
  Quranic 233 (2.3%) 10 (0.6%) 243 (2.1%)
  Primary 2919 (28.5%) 397 (24.5%) 3316 (28.0%)
  Secondary 3271 (32.0%) 565 (34.9%) 3836 (32.4%)
  Postsecondary 1973 (19.3%) 434 (26.8%) 2407 (20.3%)
 Service entry point (%)
  HCT 2177 (44.3%) 267 (36.0%) .003 2444 (43.3%)
  VCT 665 (13.5%) 132 (17.8%) 797 (14.1%)
  Others 2068 (42.1%) 342 (46.2%) 2410 (42.6%)
Clinical
 WHO clinical stage (%)
  I 5415 (46.3%) 1125 (61.2%) <.001 6540 (61.2%)
  II 3135 (26.8%) 384 (20.9%) 3519 (20.9%)
  III 2675 (22.9%) 286 (15.7%) 2961 (15.7%)
  IV 466 (4.0%) 43 (2.4%) 509 (2.4%)
 BP systolic (mm Hg), mean (SD) 123.3 (25.0) 132.1 (23.9) <.001 125.6 (24.7)
 BP diastolic (mm Hg),mean (SD) 78.5 (14.2) 84.1 (14.5) <.001 80.0 (14.3)
 Hypertension (SBP >140 or DPB >90 mm Hg) (%) 1013 (22.4%) 320 (34.2%) <.001 1333 (24.4%)
 ART regimen line (%) .11
  First line 12,493 (98.5%) 1978 (98.6%) 14,471 (98.5%)
  Second line 192 (1.5%) 29 (1.4%) 221 (1.5%)
 ART regimen (%)
  AZT-based 2987 (25.4%) 575 (30.3%) <.001 3562 (26.2%)
  TDF-based 7672 (65.5%) 1161 (61.2%) 8833 (64.9%)
  Others 1062 (9.1%) 161 (8.5%) 1223 (9.0%)
 CD4 count <500 cells/μL (%) 4567 (66.0%) 541 (47.5%) <.001 5108 (63.4%)